4 January 2023
At the meeting of 6 December 2022 the RMA:
Determined Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
atrial fibrillation and atrial flutter | 1/2023 | 2/2023 |
malignant neoplasm of the prostate | 3/2023 | 4/2023 |
epicondylitis | 5/2023 | 6/2023 |
These SOPs revoke the SOPs previously determined for these conditions.
The above SOPs take effect from 23 January 2023.
Decided to Undertake Consultation regarding:
Condition | Reasons for Decision | Date for Final Decision |
---|---|---|
melioidosis | Intention to remove one or more factors | April 2023 |
chronic myeloid leukaemia | Intention to remove one or more factors | April 2023 |
Completed Investigations
The above determinations conclude the previously advertised investigations into:
New Investigations
Decided to advertise the following investigations:
- chickenpox
- fracture
- hereditary spherocytosis
- mesothelioma
- myasthenia gravis
- myelodysplastic neoplasm (syndrome)
- trigeminal neuralgia
- trigeminal neuralgia or trigeminal neuropathy
- retinal burn
- heat-induced burn (focussed review - definition of 'external burn')
- plantar fibromatosis
The above investigation notices appear in the Government Notices Gazette of 4 January 2023.